LIST OF FIGURES
• FIGURE 27
• FIGURE 28
INTERMEDIATE-ACTING DRUGS WILL CONTINUE TO DOMINATE THE HUMAN INSULIN BIOLOGICS MARKET TILL 2020 .................................................................................... 69
NORTH AMERICA IS EXPECTED TO DOMINATE THE INTERMEDIATE-ACTING HUMAN INSULIN BIOLOGICS MARKET DURING THE STUDY PERIOD ........................................................................... 71
• FIGURE 29 INSULIN ANALOGS & BIOSIMILAR DRUGS POISED TO GROW AT THE FASTEST RATE .................................. 75
• FIGURE 30
• FIGURE 31
• FIGURE 32
• FIGURE 33
LANTUS EXPECTED TO HOLD THE LARGEST SHARE OF INSULIN ANALOGS & BIOSIMILAR BRANDS MARKET TILL 2020 .................................................................................................... 76
ASIA-PACIFIC POISED TO BE THE FASTEST-GROWING MARKET FOR NOVORAPID DURING THE FORECAST PERIOD .................................................................................................................................... 79
HUMULIN IS POISED TO BE THE FASTEST-GROWING HUMAN INSULIN BIOLOGICS BRANDS DURING 2015-2020 ............................................................................................................................ 82
INSULIN PENS TO DOMINATE THE HUMAN INSULIN DELIVERY DEVICES MARKET DURING THE FORECAST PERIOD ( 2015 – 2020 ).............................................................................................................. 87
• FIGURE 34 APAC TO DOMINATE THE HUMAN INSULIN PEN NEEDLES MARKET BY 2020 ................................................ 91
• FIGURE 35 INDIA WILL HAVE THE HIGHEST DIABETES POPULATION BY 2030 ................................................................. 97
• FIGURE 36 MARKET TRENDS : NORTH AMERICAN HUMAN INSULIN MARKET ( 2015-2020 )........................................... 102
• FIGURE 37 MARKET TRENDS : EUROPEAN HUMAN INSULIN MARKET ( 2015-2020 )....................................................... 108
• FIGURE 38 ASIA-PACIFIC HUMAN INSULIN MARKET SNAPSHOT , 2015-2020 ................................................................ 117
• FIGURE 39
LEADING PLAYERS ADOPTED THE STRATEGY OF GEOGRAPHIC EXPANSIONS TO STRENG THEN THEIR MARKET POSITIONING DURING 2012 TO 2015 ......................................................................... 126
• FIGURE 40 GLOBAL HUMAN INSULIN MARKET SHARE , BY KEY PLAYER ( 2014 )............................................................ 127
• FIGURE 41 GLOBAL HUMAN INSULIN DRUGS MARKET RANKING , BY KEY PLAYER ( 2014 )........................................... 129
• FIGURE 42 GLOBAL HUMAN INSULIN DELIVERY DEVICES MARKET RANKING , BY KEY PLAYER ( 2014 )....................... 130
• FIGURE 43
CONTINUOUS GEOGRAPHIC EXPANSION IS STIMULATING MARKET COMPETITION FOR CAPACITY BUILDING AMONG KEY PLAYERS ......................................................................................... 131
• FIGURE 44 GEOGRAPHIC REVENUE MIX OF THE TOP 5 MARKET PLAYERS * ( 2014 )....................................................... 139
• FIGURE 45
• FIGURE 46
LEADING COMPANIES ARE FOCUSING ON CAPACITY BUILDING TO STRENGTHEN THEIR PRODUCT DEVELOPMENT & MANUFACTURING BASE ....................................................................... 141
LEADING HUMAN INSULIN MANUFACTURERS ARE FOCUSING ON PRODUCT COMMERCIALIZATION TO STRENGTHEN THEIR MARKET POSITION ............................................................. 142
• FIGURE 47 B . BRAUN MELSUNGEN AG : COMPANY SNAPSHOT ...................................................................................... 143
• FIGURE 48 BECTON , DICKINSON AND COMPANY : COMPANY SNAPSHOT ..................................................................... 145
sales @ marketsandmarkets . com www . marketsandmarkets . com
23